J&J COVID vaccine is effective against Omicron sub-variants

Safety and efficacy data of the Johnson & Johnson COVID-19 vaccine, recently published in the 'New England Journal of Medicine', found that a second dose of the jab offered up to 82% protection.

Related Keywords

South Africa , California , United States , Culver City , Patrickt Fallon , Kevin Brandt , Linda Gail Bekker , Johnson , Johnson Janssen , Pfizer , Culver City Fire Department , New England Journal , Professor Linda Gail Bekker , Coronavirus , Coronavirus Vaccine , Covid 19 , Covid 19 Vaccine , J Ampj Covid 19 Vaccine , Isonke Study Researchers , Omicron Sub Variants , Ocal ,